Form 4: Fortress Biotech CFO Receives Stock Grant
Insider Transaction (Form 4)
David Jin, Chief Financial Officer of Fortress Biotech, Inc., received 1,190 shares of common stock on October 1, 2026.
Summary
- Grant/award: acquired 1,190 Common Stock, par value $0.001 at $1.82 ($2,165) on October 1, 2026; holds 1,652,761 after (Direct).
Sentiment
Score: 5
Explanation: StockSavvy.ai views this as routine: the reported changes are grants, option exercises, tax withholding or similar administrative transactions, which carry limited directional signal.
Insider Transactions
David Jin — Officer (Chief Financial Officer)
| Date | Transaction | Security | Shares | Price | Value | Held After |
|---|---|---|---|---|---|---|
| 2026-10-01 | Grant/award | Common Stock, par value $0.001 | 1,190 | $2 | $2.2K | 1,652,761 |
Key Dates
| Date | Description |
|---|---|
| 2026-10-01 | Grant/award (1,190 shares) |
Keywords
insider transaction, Form 4, FBIO, Fortress Biotech, Inc., neutral, David Jin
Disclaimer:The information provided here is for general informational purposes only and does not constitute financial advice, recommendation, or endorsement of any kind. It may contain errors or omissions. You should not rely on this information to make financial decisions. Always seek the advice of a qualified financial professional before making any investment or financial decisions. Use of this information is at your own risk.